Variables Associated with Relapse in Cases with Chronic HBV Infection who had Virological and Biochemical Response to Adefovir Treatment
暂无分享,去创建一个
M. Fincancı | Ferda Soysal | N. Tunc | H. Polat | C. Muderrisoglu | B. Ceylan | G. Eren
[1] K. Yuen,et al. 96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B. , 2008, Journal of hepatology.
[2] J. Cadranel,et al. [Is it possible to stop nucleos(t)ide analogue based therapy in chronic hepatitis B?]. , 2008, Gastroenterologie clinique et biologique.
[3] S. Won,et al. Efficacy of adefovir dipivoxil in the treatment of lamivudine‐resistant hepatitis B virus genotype C infection , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[4] M. Mohamadnejad. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. , 2006, Archives of Iranian medicine.
[5] William M. Lee,et al. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. , 2004, Gastroenterology.
[6] M. Wulfsohn,et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. , 2003, The New England journal of medicine.
[7] M. Wulfsohn,et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. , 2003, The New England journal of medicine.
[8] Ding-Shinn Chen,et al. Global control of hepatitis B virus infection. , 2002, The Lancet. Infectious diseases.
[9] Ding‐Shinn Chen,et al. From hepatitis to hepatoma: lessons from type B viral hepatitis. , 1993, Science.